Achieving positive rehabilitation outcomes in a child with von Hippel–Lindau disease following complete resection of a cerebellar hemangioblastoma: a case report
- Authors: Miroshnikova A.S.1, Petrichenko А.V.1, Ostreikov I.F.2, Kuzovlev А.N.3, Spiridonova E.A.3, Khoroshilov S.E.4, Karelin A.F.1
-
Affiliations:
- Dmitry Rogachev National Medical Research Center for Children’s Hematology, Oncology and Immunology
- Russian Medical Academy of Continuous Professional Education
- Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
- Main Military Clinical Hospital named after academician N.N. Burdenko
- Issue: Vol 7, No 4 (2025)
- Pages: 313-322
- Section: CASE REPORT
- URL: https://bakhtiniada.ru/2658-6843/article/view/363666
- DOI: https://doi.org/10.36425/rehab694067
- EDN: https://elibrary.ru/PYXHIF
- ID: 363666
Cite item
Full Text
Abstract
Von Hippel–Lindau disease is a rare, congenital, multisystemic hereditary disorder classified as a phakomatosis. It is characterized by multiple benign and malignant angiomatous tumors. Hemangioblastoma of the central nervous system is classified as a rare, highly vascularized, benign tumor. This is one of the most common tumor types associated with von Hippel-Lindau disease. The condition usually has a long asymptomatic phase, so it often goes undiagnosed until adulthood.
This work presents positive rehabilitation outcomes for a 16-year-old girl with von Hippel-Lindau disease, which manifested as multiple cystic and solid lesions in the posterior cranial fossa. Rehabilitation took place at the Medical and Rehabilitation Research Center Russkoye Pole. A long rehabilitation period allowed for the gradual achievement of clinical goals, such as restoration of clear consciousness, safe and stable movement patterns, motor skills, voice and respiratory functions, and functional swallowing. A significant improvement in quality of life was observed after the patient received comprehensive, long-term medical rehabilitation from a multidisciplinary team. The local psychologists helped the girl and her mother overcome their difficult situation caused by the disease and adopt an optimistic outlook on their future, despite the high risk of new tumors.Continuous rehabilitation efforts enabled the girl to successfully graduate from school and enter a higher education institution.
The girl did not fully recover. Targeted therapy with belzutifan was prescribed because of the presence of slow-growing lesions in the brain and spinal cord. The planned duration of the targeted therapy is three years.
About the authors
Alexandra S. Miroshnikova
Dmitry Rogachev National Medical Research Center for Children’s Hematology, Oncology and Immunology
Email: ruspole@fnkc.ru
Russian Federation, Moscow
Аnna V. Petrichenko
Dmitry Rogachev National Medical Research Center for Children’s Hematology, Oncology and Immunology
Email: a.shvarova@rambler.ru
ORCID iD: 0000-0001-6876-7898
SPIN-code: 6906-6292
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowIvan F. Ostreikov
Russian Medical Academy of Continuous Professional Education
Email: ifo_41@mail.ru
ORCID iD: 0000-0002-4863-1958
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowАrtem N. Kuzovlev
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
Email: artem_kuzovlev@mail.ru
ORCID iD: 0000-0002-5930-0118
SPIN-code: 8648-3771
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowElena A. Spiridonova
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
Author for correspondence.
Email: spiridonova.e.a@gmail.com
ORCID iD: 0000-0002-5230-5725
SPIN-code: 1729-8002
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowSergey E. Khoroshilov
Main Military Clinical Hospital named after academician N.N. Burdenko
Email: intensive@list.ru
ORCID iD: 0000-0002-0427-8099
SPIN-code: 7071-6642
MD, Dr. Sci. (Medicine)
Russian Federation, MoscowAlexander F. Karelin
Dmitry Rogachev National Medical Research Center for Children’s Hematology, Oncology and Immunology
Email: Alexandr.Karelin@dgoi.ru
ORCID iD: 0000-0003-0533-9233
MD, Cand. Sci. (Medicine)
Russian Federation, MoscowReferences
- Daniels AB, Tirosh A, Huntoon K, et al.; International VHL Surveillance Guidelines Consortium. Guidelines for surveillance of patients with Von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance. Cancer. 2023;129(19):2927–2940. doi: 10.1002/cncr.34896 EDN: CXZDLT
- Zhang Y, Nguyen CC, Zhang NT, et al. Neurological applications of belzutifan in Von Hippel-Lindau disease. Neuro Oncol. 2023;25(5):827–838. doi: 10.1093/neuonc/noac234 EDN: NTJCEA
- Palavani LB, Camerotte R, Vieira Nogueira B, et al. Innovative solutions? Belzutifan therapy for hemangioblastomas in Von Hippel-Lindau disease: a systematic review and single-arm meta-analysis. J Clin Neurosci. 2024;128:110774. doi: 10.1016/j.jocn.2024.110774 EDN: ZOAGWE
- Fiorini G, Schofield CJ. Biochemistry of the hypoxia-inducible factor hydroxylases. Curr Opin Chem Biol. 2024;79:102428. doi: 10.1016/j.cbpa.2024.102428 EDN: YTDDNE
- Volkova MI, Turupaev KA, Filippova MG, et al. Renal cell carcinoma associated with Von Hippel-Lindau syndrome: an ambispective study. J Modern Oncology. 2025;27(2):122–128. doi: 10.26442/18151434.2025.2.203226 EDN: GKTWUN
- Khan MM, Hall WA, Belkhair S. Hemangioblastoma. 2025 Jun 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
- Takami H, Graffeo CS, Perry A, et al. Presentation, imaging, patterns of care, growth, and outcome in sporadic and Von Hippel-Lindau-associated central nervous system hemangioblastomas. J Neurooncol. 2022;159(2):221–231. doi: 10.1007/s11060-022-04021-8 EDN: OXVMXG
- Tos SM, Hajikarimloo B, Mantziaris G, et al. Comparative analysis of stereotactic radiosurgery outcomes for supratentorial hemangioblastomas in Von Hippel-Lindau disease and sporadic cases: a multi-center international study. J Clin Neurosci. 2024;129:110879. doi: 10.1016/j.jocn.2024.110879 EDN: IJSZES
- Sharma A, Ambulkar K, Karlekar M, et al. Pediatric and adolescent Von Hippel-Lindau disease: tumor profiles, genotype-phenotype correlation and comparison with adults. J Endocrinol Invest. 2025;48(7):1635–1647. doi: 10.1007/s40618-025-02571-y
- Vasilenko AV, Lavrik MТ, Grigoreva PA. Current methods of postsurgical rehabilitation in benign brain tumor patients. Rehabilitology. 2024;2(2):197–206. doi: 10.17749/2949-5873/rehabil.2024.8 EDN: GAUTYH
- Stepanova AM, Gameeva EV, Germanova OV, Ognev YuN. Modern technologies for the rehabilitation of cancer patients: an overview of international experience. Malignant tumours. 2022;12(3s1):48–56. (In Russ.) doi: 10.18027/2224-5057-2022-12-3s1-48-56 EDN: WAIOAO
- Borodina ID, Kharchikov DV. Problems of rehabilitation of children with benign tumors of the central nervous system and evaluation of its effectiveness. Natsional’naya assotsiatsiya uchenykh. 2023;(87-2):6–12. doi: 10.31618/nas.2413-5291.2023.2.87.712 EDN: UMCPAS
- Boström P, Lovio R, Forslin H, Van’t Hooft I. Feasibility of a digitalised cognitive training programme in children treated for brain tumours. Acta Paediatr. 2025;114(10):2619–2623. doi: 10.1111/apa.70149
- Vashura AYu, Ryabova AA, Lukina SS, et al. The influence of nutritional changes on the motor skills in children with tumors of central nervous system and acute lymphoblastic leukemia in remission. Physical and rehabilitation medicine, medical rehabilitation. 2019;1(3):18–26. doi: 10.36425/2658-6843-2019-3-18-26 EDN: LPGENT
- Samargia-Grivette S, Hartley H, Walsh K, et al. RЕhabilitation Approaches in CHildren with cerebellar mutism syndrome (REACH): an international cross-disciplinary survey study. J Pediatr Rehabil Med. 2024;17(2):185–197. doi: 10.3233/PRM-230006
- Suponeva NA, Arestova AS, Melnik EA, et al. Validation of the Medical Research Council Sum Score (MRCSS) for use in Russian-speaking patients with chronic inflammatory demyelinating polyneuropathy. Neuromuscular diseases. 2023;13(1):68–74. doi: 10.17650/2222-8721-2023-13-1-68-74 EDN: GFBCQG
- Lutski L, Treger Y. Quality assessment in medical rehabilitation. Physical and rehabilitation medicine, medical rehabilitation. 2020;2(1):39–48. doi: 10.36425/rehab19266 EDN: VPBNAA
- Belkin AA, Alexandrova EV, Akhutina TV, et al. Chronic disorders of consciousness: guidelines of the All-Russian Public Organization “Federation of Anesthesiologists and Reanimatologists”. Alexander Saltanov intensive care herald. 2023;(3):7–42. doi: 10.21320/1818-474X-2023-3-7-42 EDN: SSLNAY
- Shaaban A, Tos SM, Mantziaris G, et al. Outcomes after stereotactic radiosurgery for intracranial hemangioblastoma in Von Hippel-Lindau disease and sporadic cases: an international multicenter study. Neurosurgery. 2025. doi: 10.1227/neu.0000000000003579
- Ahmad S, Muhlebner A, Snijders TJ, et al. Somatostatin receptor 2A expression in Von Hippel-Lindau-related hemangioblastomas. Cancer. 2024;130(20):3473–3479. doi: 10.1002/cncr.35418 EDN: COFVHX
- Takayanagi S, Takami H, Tanaka S, Saito N. Hemangioblastoma and Von Hippel-Lindau disease. (In Japanese). No Shinkei Geka. 2022;50(1):101–110. doi: 10.11477/mf.1436204535
- Wach J, Basaran AE, Vychopen M, et al. Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and Von Hippel-Lindau disease: a multicenter study. Neuro Oncol. 2025;27(6):1567–1578. doi: 10.1093/neuonc/noaf041 EDN: UZEJEB
- Sundaram M, Atkinson C, Cooper C, et al. The impact of surgery on patients with Von Hippel-Lindau-associated tumors: an international patient survey. Oncologist. 2025;30(9):oyaf206. doi: 10.1093/oncolo/oyaf206
- Nath SR, Grewal P, Cho T, Mao-Draayer Y. Familial multiple sclerosis in patients with Von Hippel-Lindau disease. BMC Neurol. 2022;22(1):80. doi: 10.1186/s12883-022-02604-6 EDN: VRRNQW
- Lee AY, Leung DK, Leung CH, et al. Presentation, management, and clinical outcomes of Von Hippel-Lindau syndrome. Hong Kong Med J. 2025. doi: 10.12809/hkmj2412496
- Malievsky OA, Malievskaya RI, Malievsky VA, Tulpakov AN. Preclinical diagnostics of Von Hippel-Lindau syndrome in a child. Problems of endocrinology. 2024;70(1):100–104. doi: 10.14341/probl13280 EDN: JWYBMC
Supplementary files


